Epstein-Barr virus (EBV) infection has been postulated to be an early event involved in the pathogenesis of nasopharyngeal carcinomas (NPC). The lack of representative premalignant nasopharyngeal epithelial cell system for EBV infection has hampered research investigation into the regulation and involvement of EBV infection in NPC pathogenesis. We have compared the efficiency of EBV infection in nasopharyngeal epithelial cells with different biological properties including immortalized, primary and cancerous nasopharyngeal epithelial cells. EBV infection could be achieved in all the nasopharyngeal epithelial cells examined with variable infection rate. TGF-b effectively enhanced EBV infection into nasopharyngeal epithelial cells both in the immortalized and primary nasopharyngeal epithelial cells. Stable infection of EBV was achieved in a telomerase-immortalized nasopharyngeal epithelial cell line, NP460hTert. The expression pattern of EBVencoded genes and biological properties of this EBV infected cell line on long-term propagation were monitored. The EBVinfected nasopharyngeal epithelial cells acquired anchorage-independent growth and exhibited invasive growth properties on prolonged propagation. A distinguished feature of this EBV-infected nasopharyngeal epithelial cell model was its enhanced ability to survive under growth factor and nutrient starvation. This was evidenced by the suppressed activation of apoptotic markers and sustained activation of pAkt of EBV-infected cells compared to control cells under nutrient starvation. Examination of cytokine profiles of EBV-infected NP460hTert cells to nutrient and growth factor deprivation revealed upregulation of expression of MCP-1 and GRO-a. The establishment of a stable EBV infection model of premalignant nasopharyngeal epithelial cells will facilitate research investigation into the pathogenic role of EBV in NPC development.
Infection of Epstein-Barr virus (EBV) is ubiquitous and more than 95% of the adult population world-wide is infected with this virus.1 EBV infection is life-long and largely asymptomatic. EBV is implicated as an etiological agent in several human malignancies of either lymphoid or epithelial origin. These include Burkitt's lymphoma, Hodgkin's lymphoma, nasal T/NK lymphomas, undifferentiated nasopharyngeal carcinomas (NPC), gastric adenocarcinomas, smooth muscle tumors and various B-cells lymphomas in AIDS patients or transplant recipients with compromised immune functions.
2-4EBV infection can be detected in most, if not all, undifferentiated NPC, regardless of geographical and ethnical origin of NPC patients.2 Expression of latent EBV genes including EBER, EBNA1, LMP1 and LMP2A as well as lytic EBV genes, such as BZLF1, could be detected in cancer cells inside the nasopharyngeal carcinoma specimens. Clonal infection of EBV has been detected in precancerous lesions of NPC, implicating its involvement at the early stage of NPC pathogenesis.5 EBV infection has long been postulated to play an important role in transformation of premalignant ...